JP3160862B2 - Bone-fortified foods, feeds and pharmaceuticals - Google Patents

Bone-fortified foods, feeds and pharmaceuticals

Info

Publication number
JP3160862B2
JP3160862B2 JP30950490A JP30950490A JP3160862B2 JP 3160862 B2 JP3160862 B2 JP 3160862B2 JP 30950490 A JP30950490 A JP 30950490A JP 30950490 A JP30950490 A JP 30950490A JP 3160862 B2 JP3160862 B2 JP 3160862B2
Authority
JP
Japan
Prior art keywords
bone
feed
water
soluble fraction
whey protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP30950490A
Other languages
Japanese (ja)
Other versions
JPH04183371A (en
Inventor
幸宏 ▲高▼田
直道 小林
隆 丸山
政利 八尋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Priority to JP30950490A priority Critical patent/JP3160862B2/en
Publication of JPH04183371A publication Critical patent/JPH04183371A/en
Application granted granted Critical
Publication of JP3160862B2 publication Critical patent/JP3160862B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】TECHNICAL FIELD OF THE INVENTION

本発明は、乳清蛋白の水可溶性画分または、その蛋白
分解酵素分解物の水可溶性画分を含有せしめて骨強化食
品、骨強化飼料または骨強化剤に関する。 さらに、本発明は、これらの水可溶性画分に適当なカ
ルシウム塩を併用せしめてなる骨強化食品、骨強化飼料
または骨強化剤に関する。
The present invention relates to a bone-enhancing food, a bone-enhancing feed or a bone-enhancing agent containing a water-soluble fraction of whey protein or a water-soluble fraction of a proteolytic enzyme degradation product thereof. Furthermore, the present invention relates to a bone-enhancing food, a bone-enhancing feed or a bone-enhancing agent obtained by using an appropriate calcium salt in combination with these water-soluble fractions.

【0002】[0002]

【従来の技術】[Prior art]

近年、高齢化に伴い、骨粗鬆症、骨折および腰痛など
の各種骨疾患の患者が増加している。これらはカルシウ
ムの摂取不足、カルシウム吸収能の低下、活性化ビタミ
ンD3分泌の不足およびホルモンのアンバランスなどが原
因であるといわれている。 現在カルシウムの補給を目的として炭酸カルシウム、
乳酸カルシウム、およびリン酸カルシウムなどのカルシ
ウム塩や牛骨粉、卵殻および魚骨粉などの天然カルシウ
ム剤が使われている。 また、骨粗鬆症や、骨強化のための医薬としては、ビ
タミン1α(OH)D3およびカルシトニン製剤などがあ
る。 しかし、これらは医薬そのものであって、食品素材に
使う安全でしかも長期的にマイルドな条件で摂取して、
骨強化をする物質については知られていない。
In recent years, as the population ages, the number of patients suffering from various bone diseases such as osteoporosis, fractures and back pain is increasing. It is said insufficient intake of calcium, lowering of calcium absorbing ability, and the like imbalance deficiency and hormone-activated vitamin D 3 secretion is the cause. Currently calcium carbonate for the purpose of supplementing calcium,
Calcium salts such as calcium lactate and calcium phosphate and natural calcium agents such as bovine bone meal, eggshell and fish bone powder are used. Pharmaceuticals for osteoporosis and bone strengthening include vitamin 1α (OH) D 3 and calcitonin preparations. However, these are medicines themselves, safe and long-term ingestion under mild conditions used for food materials,
No known bone strengthening substances are known.

【0003】[0003]

【発明が解決しようとしている課題】[Problems to be solved by the invention]

乳は天然素材としてすぐれているが、乳をそのまま食
品または医薬として摂取としたとしても乳清蛋白および
ペプチドを多量に摂取利用することができない。 本発明は、このような従来の乳由来の乳清蛋白および
ペプチドの利用ならびに骨強化を目的としてなされたも
のである。すなわち、本発明は、乳清蛋白及びペプチド
を多量に吸収することができ、骨を強化することのでき
る骨強化食品、骨強化飼料及び骨強化剤を提供すること
を課題とする。
Milk is excellent as a natural material, but even if milk is taken as food or medicine as it is, a large amount of whey proteins and peptides cannot be consumed. The present invention has been made for the purpose of utilizing such conventional milk-derived whey proteins and peptides and for strengthening bones. That is, an object of the present invention is to provide a bone-enhancing food, a bone-enhancing feed, and a bone-enhancing agent that can absorb a large amount of whey proteins and peptides and can strengthen bone.

【0004】[0004]

【課題を解決するための手段】[Means for Solving the Problems]

本発明者らは、乳清蛋白及びペプチドを吸収すること
ができ、またカルシウムの吸収をも促進することのでき
る食品、飼料及び医薬を、乳清から得ることについて検
討を行った。その結果、乳清の水可溶性画分あるいは、
蛋白分解酵素により加水分解して得られる水可溶性画分
あるいはこれらの画分から逆浸透(RO)膜または電気透
析(ED)等により乳清由来の塩を除いた蛋白混合物は、
骨を強化する作用があり、さらにこれらに吸収性の良い
カルシウム剤を添加することによりカルシウム吸収を一
段と促進することができることを見出した。
The present inventors have studied the production of foods, feeds, and medicines that can absorb whey proteins and peptides and can also promote calcium absorption from whey. As a result, the water-soluble fraction of whey or
A water-soluble fraction obtained by hydrolysis with a protease, or a protein mixture obtained by removing whey-derived salts from these fractions by a reverse osmosis (RO) membrane or electrodialysis (ED), etc.
They have the effect of strengthening bones, and have found that calcium absorption can be further promoted by adding a calcium agent having good absorbability to these.

【0005】 そして、これらの知見に基づいて骨を強化する作用を
有する食品、医薬あるいは飼料を得るに至ったものであ
る。 すなわち、本発明は、次の骨強化食品、骨強化飼料及
び骨強化剤に関する。 (1)分子量が45,000〜10,000、等電点がp13〜8であ
る、乳清蛋白の水可溶性画分を含有せしめなる骨強化食
品、骨強化飼料または骨強化剤。 (2)請求項1記載の乳清蛋白の水可溶性画分と、吸収
性のよいカルシウム塩とを含有せしめてなる骨強化食
品、骨強化飼料または骨強化剤。 (3)乳清蛋白の水可溶性画分を蛋白分解酵素で酵素分
解し、得られる分子量20,000〜300の蛋白分解酵素分解
物よりなる水可溶性画分を含有せしめてなる骨強化飼料
または骨強化剤。 (4)請求項3記載の蛋白分解酵素分解物よりなる水溶
性画分と、吸収性のよいカルシウム塩とを含有せしめて
なる骨強化飼料または骨強化剤。
[0005] Based on these findings, a food, medicine or feed having an action of strengthening bones has been obtained. That is, the present invention relates to the following bone-enhancing food, bone-enhancing feed, and bone-enhancing agent. (1) A bone-enhancing food, a bone-enhancing feed or a bone-enhancing agent having a molecular weight of 45,000 to 10,000 and an isoelectric point of p13 to 8 and containing a water-soluble fraction of whey protein. (2) A bone-enhancing food, a bone-enhancing feed or a bone-enhancing agent comprising the water-soluble fraction of whey protein according to claim 1 and a calcium salt having good absorbability. (3) A bone-fortifying feed or a bone-strengthening agent obtained by enzymatically decomposing a water-soluble fraction of whey protein with a protease and containing the resulting water-soluble fraction of a protease having a molecular weight of 20,000 to 300. . (4) A bone-strengthening feed or a bone-strengthening agent comprising a water-soluble fraction comprising the proteolytic enzyme hydrolyzate according to claim 3 and a calcium salt having good absorbability.

【0006】[0006]

【発明の実施の形態】BEST MODE FOR CARRYING OUT THE INVENTION

本発明における原料の乳は、牛乳、人乳、ヤギ乳、羊
乳などがあげられる。乳清は、乳または脱脂乳に酸を加
えるかまたは、レンネットを作用させて生ずる凝固物を
除いた透明な黄緑色の液体であって、チーズまたはカゼ
イン製造の副産物として得られる。 本発明における乳清蛋白は、この乳清を限外濾過、逆
浸透法、クロマトグラフィー、透析などにより得られる
水可溶性の蛋白である。特に分子量10,000〜45,000で等
電点がpI3〜8の乳清蛋白の水可溶性画分は望ましい。
The raw material milk in the present invention includes milk, human milk, goat milk, sheep milk and the like. Whey is a clear yellow-green liquid that is free of coagulum produced by adding acid or rennet to milk or skim milk, and is obtained as a by-product of cheese or casein production. The whey protein in the present invention is a water-soluble protein obtained by subjecting this whey to ultrafiltration, reverse osmosis, chromatography, dialysis and the like. In particular, a water-soluble fraction of whey protein having a molecular weight of 10,000 to 45,000 and an isoelectric point of pI 3 to 8 is desirable.

【0007】 本発明ではこの画分をそのまま、または脱塩濃縮した
りあるいは乾燥したりして使用する。蛋白分解酵素によ
る酵素分解を行う場合には、この溶液あるいは懸濁液に
蛋白分解酵素を添加し酵素分解する。蛋白分解酵素に
は、ペプシン、トリプシン、キモトリプシン等を使用す
ることができる。酵素反応は、溶液または懸濁液を使用
する酵素の至適pH、至適温度になるように調製し、酵素
を添加し、数10分〜数時間放置乃至撹拌を行うことによ
ってなされる。このようにすると、分子量20,000〜300
程度の蛋白分解酵素分解物を得ることができる。この蛋
白分解酵素分解物は乳清蛋白またはペプチドよりなるも
のである。
In the present invention, this fraction is used as it is, or after being desalted and concentrated or dried. In the case of performing enzymatic degradation using a proteolytic enzyme, a proteolytic enzyme is added to this solution or suspension to perform enzymatic degradation. Pepsin, trypsin, chymotrypsin and the like can be used as the protease. The enzyme reaction is carried out by preparing a solution or a suspension so as to have an optimum pH and an optimum temperature of the enzyme to be used, adding the enzyme, and allowing the mixture to stand or stir for several tens of minutes to several hours. In this way, the molecular weight is 20,000-300
A degree of proteolytic degradation can be obtained. This proteolytic enzyme hydrolyzate is composed of whey protein or peptide.

【0008】 本発明における水可溶性画分は、吸収性のよいカルシ
ウム塩を添加することが望ましい。この時には塩化カル
シウム、炭酸カルシウム、乳酸カルシウム、卵殻あるい
は牛乳由来のカルシウム等の吸収性のよいカルシウム塩
あるいはその含有物を添加するとよい。 本発明では、このような吸収性のよいカルシウム塩含
有物をも含めて吸収性のよいカルシウム塩という。
In the present invention, it is desirable to add a calcium salt having good absorbability to the water-soluble fraction. At this time, it is preferable to add a calcium salt having good absorbability such as calcium chloride, calcium carbonate, calcium lactate, calcium derived from eggshell or milk, or a content thereof. In the present invention, such a calcium salt-containing substance having good absorbability is referred to as a calcium salt having good absorbability.

【0009】 本発明の骨強化食品、骨強化飼料あるいは骨強化剤
は、これらの水可溶性分画、蛋白分解酵素による水可溶
性画分の酵素分解物よりなる水可溶性画分、あるいはこ
れらの水可溶性画分に吸収性のよいカルシウム塩を添加
してなるもの等を含有するものである。 食品の例を挙げると、飲料、ゼリー、錠剤、パン、
麺、スープ、ソーセージ等があり、飼料には、飼料添加
物、その他の飼料が、さらに骨強化剤として経口的に投
与できる錠剤、顆粒剤、液剤等が挙げられる。これらの
意訳は経口的に投与され、骨粗鬆症(オステオポロー
ゼ)の予防あるいは治療に用いられる。投与量は成人、
約4000〜8000mg/1日を数回に分けて投与することが望ま
しい。また、前記画分は元来、乳の成分であって、ラッ
トによる動物試験でも急性毒性は認められなかった。
The bone-enriched food, bone-enriched feed or bone-enhancing agent of the present invention comprises a water-soluble fraction of these, a water-soluble fraction comprising an enzymatically degraded product of a water-soluble fraction by a protease, or a water-soluble fraction thereof. It contains a product obtained by adding a calcium salt having good absorbability to the fraction. Food examples include beverages, jellies, tablets, breads,
There are noodles, soups, sausages and the like, and the feed includes tablets, granules, liquids and the like which can be orally administered with feed additives and other feeds as a bone strengthening agent. These meanings are orally administered and used for prevention or treatment of osteoporosis (osteoporosis). The dosage is for adults,
It is desirable to administer about 4000 to 8000 mg / day in several divided doses. The fraction was originally a component of milk, and no acute toxicity was observed in animal tests using rats.

【0010】 次に本発明の乳清ペプチド及び蛋白の製造法を実施例
をあげて説明する。
Next, a method for producing the whey peptide and the protein of the present invention will be described with reference to examples.

【実施例1】 乳清蛋白(WP−N)の調製法 脱脂乳100に6N塩酸を滴下して、pH4.7にした。1時
間放置後、沈澱したカゼインを遠心して除き乳清を得
た。 この乳清を膜面積が0.72m2のDOW社製のUF膜GR61PP
(分画分子量2万ダルトン)を用いて濃縮した。 さらにダイアフィルトレーションにより乳清蛋白質を
精製した。4.31の精製液を蒸留水にて十分に透析した。
透析後、凍結乾燥して乳清蛋白画分(WP)を含む粉末46
8gを得た。
Example 1 Preparation method of whey protein (WP-N) 6N hydrochloric acid was dropped into skim milk 100 to pH 4.7. After standing for 1 hour, the precipitated casein was removed by centrifugation to obtain whey. This whey is coated with DOW UF membrane GR61PP with a membrane area of 0.72 m 2
(Fraction molecular weight: 20,000 daltons). The whey protein was further purified by diafiltration. The purified liquid of 4.31 was sufficiently dialyzed against distilled water.
After dialysis, freeze-dried and powder containing whey protein fraction (WP) 46
8 g were obtained.

【0011】 WPを90mm×500mmのG−100カラムにかけこれを分画
し、分画分子量10,000〜45,000の乳清蛋白(WP−N)18
0gを得た。
The WP is applied to a G-100 column of 90 mm × 500 mm and fractionated, and the fraction is fractionated. Whey protein (WP-N) 18 having a molecular weight cutoff of 10,000 to 45,000 is used.
0 g was obtained.

【実施例2】 乳清蛋白トリプシン分解物(WP−T)の調製 実施例1に記載した方法で、得られた乳清蛋白(WP−
N)200gを4.5の蒸留水に溶解した。
Example 2 Preparation of Whey Protein Tryptic Hydrolyzate (WP-T) Whey protein (WP-T) obtained by the method described in Example 1
N) 200 g was dissolved in 4.5 distilled water.

【0012】 これに4gのトリプシンを添加し、37℃で5時間反応さ
せて、乳清蛋白トリプシン分解物を生成せしめた。その
後、84℃5分間保持して酵素を失活せしめ、凍結乾燥
し、乳清蛋白トリプシン分解物(WP−T)を含む粉末19
2gを得た。この分子量は20,000〜300であった。
[0012] 4 g of trypsin was added thereto and reacted at 37 ° C. for 5 hours to produce a whey protein trypsin hydrolyzate. Thereafter, the enzyme was inactivated by holding at 84 ° C. for 5 minutes, freeze-dried, and powdered with whey protein trypsin hydrolyzate (WP-T) 19
2 g were obtained. Its molecular weight was between 20,000 and 300.

【0013】[0013]

【実施例3】 乳清蛋白(WP−N)および乳清蛋白トリプシン分解物
(WP−T)の骨強化効果 (1)被験試料を添加したラット飼料組成 試験に使用した飼料の組成を第1表及び第2表に示
す。飼料基本成分(g/100g) 蔗 糖 49 コーンスターチ 15 トウモロコシ油 5 D−Lメチオニン 0.3 セルロース 5 ビタミン 1.2 (コリンを含む)
Example 3 Bone-Strengthening Effect of Whey Protein (WP-N) and Whey Protein Trypsin Degradate (WP-T) (1) Composition of Rat Feed Added with Test Sample The results are shown in Table 2 and Table 2. Feed basic ingredients (g / 100g) Sucrose 49 Corn starch 15 Corn oil 5 DL methionine 0.3 Cellulose 5 Vitamin 1.2 (including choline)

【0014】 [0014]

【0015】 実施例1および2で得られたWP、WP−N、WP−Tを第
2表に示すように飼料にそれぞれ別々に1.09%、1%、
1%添加し、カゼインで飼料中蛋白量が20%になるよう
調整した。飼料中カルシウム量は、すべての群で飼料g
あたりのカルシウム量が300mgとなるよう炭酸カルシウ
ムで調整した。またリン400mg、カリウム350mg、マグネ
シウム80mgナトリウム100mgになるように調整した。 (2)使用動物及び骨粗鬆症モデル動物の作成 動物は5週齢のSD系雌性ラットを用いた。骨粗鬆症モ
デルラットは、1週間予備飼育した後に卵巣摘出手術を
施し低カルシウム食で1ヵ月間飼育することにより作成
した。1試験群各7匹で試験を行った。 (3)骨強化試験 骨粗鬆症モデルラットを上記被験飼料で1ヵ月間飼育
した後、大腿骨を摘出し骨強度を破断特性測定装置で測
定した。 (4)試験結果
As shown in Table 2, WP, WP-N and WP-T obtained in Examples 1 and 2 were separately added to feed at 1.09%, 1%,
1% was added, and the amount of protein in the feed was adjusted to 20% with casein. Dietary calcium level was g
It was adjusted with calcium carbonate so that the amount of calcium per was 300 mg. Adjustments were made so that phosphorus was 400 mg, potassium was 350 mg, magnesium was 80 mg, and sodium was 100 mg. (2) Preparation of used animals and osteoporosis model animals As the animals, 5-week-old SD female rats were used. Osteoporosis model rats were prepared by preliminarily breeding for one week, performing oophorectomy, and breeding on a low calcium diet for one month. The test was performed with 7 animals in each test group. (3) Bone strengthening test After osteoporosis model rats were bred for one month with the above-mentioned test feed, the femur was excised and the bone strength was measured with a fracture characteristics measuring device. (4) Test results

【0016】 試験結果を第1図及び第2図に示す。第1図に示した
ように骨破断力は、対照群に比べ乳清蛋白(WP−N)を
加えた群および乳清蛋白トリプシン分解物(WP−T)を
加えた群で顕著に高い値を示した。第2図に示した骨破
断エネルギーも対照群や低カルシウム群に比べ、WP−N
とWP−Tを加えた群で顕著に高い値を示した。しかもシ
ャムCaCO3添加群よりも高い値を示した。このことか
ら、乳清蛋白(WP−N)および乳清蛋白トリプシン分解
物(WP−T)に骨強化作用があることが分かった。
The test results are shown in FIG. 1 and FIG. As shown in FIG. 1, the bone breaking force was significantly higher in the group to which whey protein (WP-N) was added and the group to which whey protein trypsin hydrolyzate (WP-T) was added, as compared with the control group. showed that. The bone breaking energy shown in FIG. 2 was also higher than the control group and the low calcium group in WP-N
And the group to which WP-T was added showed remarkably high values. Moreover, the value was higher than that of the sham CaCO 3 added group. From this, it was found that whey protein (WP-N) and whey protein trypsin hydrolyzate (WP-T) have a bone strengthening effect.

【0017】 本発明の食品、飼料あるいは医薬について実施齢をあ
げて具体的に示す。
[0017] The food, feed or medicine of the present invention will be specifically described with increasing working age.

【実施例4】 (WP−NまたはWP−T入り飲料) 重量% 混合異性化糖 15.0 果 汁 10.0 クエン酸 0.5 WP−NまたはWP−T 0.5 香 料 0.1 カルシウム(CaCl2) 0.1 水 73.8 上記配合比によって通常の製造法にて果汁飲料を製造
した。
Example 4 (Beverage containing WP-N or WP-T)% by weight Mixed isomerized sugar 15.0 Fruit juice 10.0 Citric acid 0.5 WP-N or WP-T 0.5 Flavor 0.1 Calcium (CaCl 2 ) 0.1 Water 73.8 Fruit juice beverages were produced according to the ratio by a usual production method.

【0018】[0018]

【実施例5】 (WP−NまたはWP−T入りゼリー) 重量% 果 汁 20.0 グニュー糖 15.0 水 飴 5.0 寒 天 1.0 WP−NまたはWP−T 0.5 香 料 0.1 カルシウム(CaCO3) 0.1 水 58.3 上記配合比によって通常の製造法にてゼリーを製造し
た。
[Example 5] (Jelly containing WP-N or WP-T) wt% fruit juice 20.0 gnu sugar 15.0 water candy 5.0 agar 1.0 agar 1.0 WP-N or WP-T 0.5 flavor 0.1 calcium (CaCO 3 ) 0.1 water 58.3 Jelly was produced according to the usual production method according to the compounding ratio.

【0019】[0019]

【実施例6】 (WP−NまたはWP−T入り錠剤) 重量% 含水結晶ブドウ糖 73.5 WP−NまたはWP−T 20.0 カルシウム(CaCl2) 5.0 シュガーエステル 1.0 香 料 0.5 上記配合比によって通常の製造法にて錠剤を製造し
た。得られた錠剤は、カルシウム及び蛋白今補強の栄養
剤として1日5〜6錠あるいは骨粗鬆症の予防または治
療に1日6〜10錠投与することができる。
[Example 6] (Tablet containing WP-N or WP-T)% by weight Hydrous crystalline glucose 73.5 WP-N or WP-T 20.0 Calcium (CaCl 2 ) 5.0 Sugar ester 1.0 Fragrance 0.5 Normal production method based on the above mixing ratio To produce tablets. The resulting tablets can be administered 5-6 tablets per day as a nutritional supplement for calcium and protein or 6-10 tablets per day for the prevention or treatment of osteoporosis.

【0020】[0020]

【実施例7】 〔イヌ飼育用飼料(ドッグフード)〕イヌ飼育用基礎飼料 重量% 大豆粕 11 脱脂粉乳 14 大豆油 4 コーン油 2 パーム油 2 とうもろこしデンプン 28 小麦粉 15 ふすま 8 ビタミン混合物1) 2 ミネラル混合物2) 9 セルロース 2 WP−NまたはWP−T 3 100 1) ビタミン混合物 ビタミンA 1500IU ビタミンD3 300IU ビタミンE 6.8mg ビタンミンB1 0.9mg ビタミンB2 0.4mg ビタミンB6 0.5mg ビタミンB12 3.4mg ビタミンC 50.0mg パントテン酸 4.0mg 葉 酸 0.2mg コリン 200.0mg ビオチン 24.4μg イノシトール 50.0mg ナイアシン 10.5mg ショ糖で2gとした。2) ミネラル混合物 CaCO3 3.0g KH2PO4 2.0g NaH2PO4 1.5g MgO 0.5g MnCO3 40.0mg FeC6H5O7 30.0mg 70%ZnO 10.0mg 55%CaCO3 4.5mg KIO3 0.65mg Na2SeO3・5H2O 0.05mg CrK(SO4)・12H2O 5.0mg ショ糖で9gとした。 上記イヌ飼育用基礎飼料100g中に上記配合量でビタミ
ン混合物及びミネラル混合物を加え通常の製造法にてイ
ヌ飼育用飼料を製造した。
[Example 7] [Dog breeding feed (dog food)] Dog breeding basic feed weight% soybean meal 11 skim milk powder 14 soybean oil 4 corn oil 2 palm oil 2 corn starch 28 wheat flour 15 bran 8 vitamin mixture 1) 2 mineral mixture 2) 9 Cellulose 2 WP-N or WP-T 3 100 1) Vitamin mixture Vitamin A 1500 IU Vitamin D 3 300 IU Vitamin E 6.8 mg Vitamin B 1 0.9 mg Vitamin B 2 0.4 mg Vitamin B 6 0.5 mg Vitamin B 12 3.4 mg Vitamin C 50.0 mg Pantothenic acid 4.0 mg Folic acid 0.2 mg Choline 200.0 mg Biotin 24.4 μg Inositol 50.0 mg Niacin 10.5 mg Sucrose was added to 2 g. 2) mineral mixture CaCO 3 3.0g KH 2 PO 4 2.0g NaH 2 PO 4 1.5g MgO 0.5g MnCO 3 40.0mg FeC 6 H 5 O 7 30.0mg 70% ZnO 10.0mg 55% CaCO 3 4.5mg KIO 3 0.65mg was 9g with Na 2 SeO 3 · 5H 2 O 0.05mg CrK (SO 4) · 12H 2 O 5.0mg sucrose. The vitamin mixture and the mineral mixture were added to the above-mentioned basic feed for dog breeding in an amount of 100 g in the above amount, and a feed for breeding dogs was produced by a usual production method.

【0021】[0021]

【発明の効果】【The invention's effect】

本発明の骨強化食品、骨強化飼料、骨強化剤は、骨を
強化する作用があることから健康食品あるいは各種の骨
関節疾患、特に骨粗鬆症の予防あるいは治療に有用であ
る。また飼料としても有用なものとなる。
The bone-fortified food, bone-strength feed, and bone-strengthening agent of the present invention are useful for preventing or treating health foods or various osteoarticular diseases, particularly osteoporosis, because they have the action of strengthening bone. It is also useful as feed.

【図面の簡単な説明】[Brief description of the drawings]

第1図及び第2図は実施例3の骨強化試験の結果をそれ
ぞれ示す。
1 and 2 show the results of the bone strengthening test of Example 3, respectively.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A23L 1/304 A23L 1/304 A61K 33/06 A61K 33/06 38/17 A61P 19/10 A61P 19/10 A23C 20/00 // A23C 20/00 C12P 21/06 C12P 21/06 A61K 37/16 (56)参考文献 特開 昭61−289846(JP,A) 特公 昭51−20578(JP,B1) 月刊フードケミカル,(1987)Vo l.3,No.6,p.25−31 (58)調査した分野(Int.Cl.7,DB名) A23L 1/305 A23J 3/08 A23J 3/34 A23L 1/304 A61K 38/17 JICSTファイル(JOIS) JAFICファイル(JOIS)────────────────────────────────────────────────── ─── Continued on the front page (51) Int.Cl. 7 Identification code FI A23L 1/304 A23L 1/304 A61K 33/06 A61K 33/06 38/17 A61P 19/10 A61P 19/10 A23C 20/00 / A23C 20/00 C12P 21/06 C12P 21/06 A61K 37/16 (56) References JP-A-61-289846 (JP, A) JP-B-51-20578 (JP, B1) Monthly Food Chemical, (1987) ) Vol. 3, No. 6, p. 25-31 (58) Field surveyed (Int.Cl. 7 , DB name) A23L 1/305 A23J 3/08 A23J 3/34 A23L 1/304 A61K 38/17 JICST file (JOIS) JAFIC file (JOIS)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】分子量が45,000〜10,000、等電点がp13〜
8である、乳清蛋白の水可溶性画分を含有せしめなる骨
強化食品、骨強化飼料または骨強化剤。
(1) a molecular weight of 45,000 to 10,000 and an isoelectric point of p13 to
8. A bone-fortified food, a bone-strength feed or a bone-strengthening agent, which comprises a water-soluble fraction of whey protein.
【請求項2】請求項1記載の乳清蛋白の水可溶性画分
と、吸収性のよいカルシウム塩とを含有せしめてなる骨
強化食品、骨強化飼料または骨強化剤。
2. A bone-enhancing food, bone-enhancing feed or bone-enhancing agent comprising the water-soluble fraction of whey protein according to claim 1 and a calcium salt having good absorbability.
【請求項3】乳清蛋白の水可溶性画分を蛋白分解酵素で
酵素分解し、得られる分子量20,000〜300の蛋白分解酵
素分解物よりなる水可溶性画分を含有せしめてなる強化
飼料または骨強化剤。
3. A fortified feed or bone fortification comprising enzymatically decomposing a water-soluble fraction of whey protein with a protease and containing the resulting water-soluble fraction comprising a protease digest having a molecular weight of 20,000 to 300. Agent.
【請求項4】請求項3記載の蛋白分解酵素分解物よりな
る水溶性画分と、吸収性のよいカルシウム塩とを含有せ
しめてなる骨強化飼料または骨強化剤。
4. A bone-strengthening feed or a bone-strengthening agent comprising a water-soluble fraction comprising the proteolytic enzyme-decomposed product according to claim 3 and a calcium salt having good absorbability.
JP30950490A 1990-11-15 1990-11-15 Bone-fortified foods, feeds and pharmaceuticals Expired - Lifetime JP3160862B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP30950490A JP3160862B2 (en) 1990-11-15 1990-11-15 Bone-fortified foods, feeds and pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30950490A JP3160862B2 (en) 1990-11-15 1990-11-15 Bone-fortified foods, feeds and pharmaceuticals

Publications (2)

Publication Number Publication Date
JPH04183371A JPH04183371A (en) 1992-06-30
JP3160862B2 true JP3160862B2 (en) 2001-04-25

Family

ID=17993794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP30950490A Expired - Lifetime JP3160862B2 (en) 1990-11-15 1990-11-15 Bone-fortified foods, feeds and pharmaceuticals

Country Status (1)

Country Link
JP (1) JP3160862B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009057287A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Food material for inhibiting the formation of osteoclast
WO2009057282A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Food material for inhibiting bone resorption
WO2009057280A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Bone-strengthening food material
WO2009057281A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE163858T1 (en) * 1991-12-26 1998-03-15 Snow Brand Milk Products Co Ltd THE BONE STRENGTHENING FACTOR AND FOODS AND DRINKS THAT CONTAIN THIS FACTOR
IT1269826B (en) * 1994-05-24 1997-04-15 Paolo Minoia USE OF OPTIACEAN ANTAGONISTS AND CALCIUM SALTS FOR THE PREPARATION OF MEDICATIONS FOR THE TREATMENT OF ENDORPHINE-MEDIATED PATHOLOGICAL FORMS
JP2974604B2 (en) * 1996-01-23 1999-11-10 雪印乳業株式会社 Basic protein composition, basic peptide composition and use thereof
JP3073439B2 (en) 1996-02-08 2000-08-07 雪印乳業株式会社 Bone formation promotion and bone resorption inhibitor
JP3018313B2 (en) * 1996-02-23 2000-03-13 雪印乳業株式会社 Bone formation promotion and bone resorption inhibitor
EP1062876A1 (en) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caseinoglycomacropeptides as calcification agent
US6649590B2 (en) 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
MXPA05010817A (en) 2003-04-08 2006-03-30 Progenics Pharm Inc Pharmaceutical formulations containing methylnaltrexone.
AR057035A1 (en) 2005-05-25 2007-11-14 Progenics Pharm Inc SYNTHESIS OF (R) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES
AR057325A1 (en) 2005-05-25 2007-11-28 Progenics Pharm Inc SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES
JP5461386B2 (en) 2007-03-29 2014-04-02 プロジェニックス ファーマシューティカルズ,インコーポレーテッド Peripheral opioid receptor antagonists and uses thereof
US20100305323A1 (en) 2007-03-29 2010-12-02 Smolenskaya Valeriya N Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
EP2240489A1 (en) 2008-02-06 2010-10-20 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
CN102617702A (en) * 2012-03-09 2012-08-01 姜浩奎 Production method of peptidoglycan

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
月刊フードケミカル,(1987)Vol.3,No.6,p.25−31

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009057287A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Food material for inhibiting the formation of osteoclast
WO2009057282A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Food material for inhibiting bone resorption
WO2009057280A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Bone-strengthening food material
WO2009057281A1 (en) 2007-11-01 2009-05-07 Snow Brand Milk Products Co., Ltd. Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast
EP2210507A1 (en) * 2007-11-01 2010-07-28 Snow Brand Milk Products Co., Ltd. Bone-strengthening food material
US8420599B2 (en) 2007-11-01 2013-04-16 Megmilk Snow Brand Co., Ltd. Bone-reinforcing food material
US8580740B2 (en) 2007-11-01 2013-11-12 Megmilk Snow Brand Co., Ltd. Bone resorption inhibitory food material for inhibiting bone resorption
EP2210507B1 (en) * 2007-11-01 2015-09-09 Megmilk Snow Brand Co., Ltd. Bone-strengthening compositions

Also Published As

Publication number Publication date
JPH04183371A (en) 1992-06-30

Similar Documents

Publication Publication Date Title
JP3160862B2 (en) Bone-fortified foods, feeds and pharmaceuticals
JP2947484B2 (en) Bone-fortified food, feed or osteoarthritis prophylactic or therapeutic drug
CA2349980C (en) Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP2001346519A (en) Method for producing fraction containing high content of milk basic cystatin and decomposed product thereof
EP2208734B1 (en) Food material for inhibiting the formation of osteoclast
JP3092874B2 (en) Whey-derived osteoblast-proliferating and bone-enhancing fraction and bone-enhanced food, feed, and pharmaceuticals containing the fraction
AU2008320271B2 (en) Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast
JP5357042B2 (en) Bone strengthening food material
JP2002000193A (en) Method for producing fraction having high milk-derived basic cystatin content and cleavaged product thereof
JPH0453471A (en) Bone-enriched food, feed and medicine
AU5185301A (en) Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
AU2008320272B2 (en) Food material for inhibiting bone resorption
JPH11310599A (en) Polymer type calcium/phosphopeptide complex
JP2964290B2 (en) Mineral absorption enhancer

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080223

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090223

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090223

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100223

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110223

Year of fee payment: 10

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110223

Year of fee payment: 10